AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,451,000 | -36.7% | 142,800 | -49.6% | 0.06% | -38.4% |
| Q3 2019 | $5,450,000 | +21.5% | 283,535 | +86.7% | 0.10% | +25.3% |
| Q2 2019 | $4,487,000 | -38.1% | 151,855 | -0.6% | 0.08% | -39.2% |
| Q1 2019 | $7,254,000 | +15.6% | 152,710 | -12.1% | 0.13% | +4.0% |
| Q4 2018 | $6,273,000 | -38.0% | 173,760 | +5.6% | 0.12% | -22.4% |
| Q3 2018 | $10,123,000 | – | 164,475 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |